{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:02:21Z","timestamp":1790179341971,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Systemic juvenile idiopathic arthritis (sJIA) is the most severe subtype of JIA, with a combination of diverse clinical manifestations and a variable clinical course. A comprehensive understanding of molecular signatures at the systems level and the discovery of molecular subtypes are the initial steps toward personalized medicine in sJIA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A blood transcriptomic dataset was collected from patients with systemic JIA (sJIA) (<jats:italic>n<\/jats:italic>\u2009=\u2009168), polyarticular JIA (<jats:italic>n<\/jats:italic>\u2009=\u2009254), oligoarticular JIA (<jats:italic>n<\/jats:italic>\u2009=\u200996), enthesitis-related arthritis (<jats:italic>n<\/jats:italic>\u2009=\u200940), and healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u2009220). Gene expression profiles were filtered for differentially expressed genes and unsupervised clustering, gene set enrichment, and network-based centrality analyses. The molecular signatures of three novel sJIA subgroups (designated as C1, C2, and C3) were investigated, focusing on their distinct features and treatment responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Neutrophil degranulation and the IL-1 signaling pathway were the shared key processes for the three subgroups. Proinflammatory signals, including TNF, IL-6, TLR, and G-CSF signaling pathways, were identified with variation across the subgroups. C1 was the most inflammatory subset with a high-risk profile for macrophage activation syndrome. The C2 subset had the most activated IL-1 and IL-18 signaling pathways. C2 and C3 have higher levels of interferon-stimulated signatures. In a canakinumab-treated dataset, treatment response was correlated with IL1B expression and NF-\u03baB signaling pathway, and neutrophil activation-associated processes were effectively suppressed in a good responder group. GSK3B and p38 MAPK inhibitors showed a significant counteracting effect on the perturbed gene expression of sJIA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Neutrophil activation was the key feature in active sJIA. The three molecular subtype scheme enables the formulation of precision medicine strategies in sJIA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13075-025-03498-8","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:09:26Z","timestamp":1738994966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"27","author":[{"given":"In-Woon","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Woo","family":"Rhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"3498_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","volume":"8","author":"A Martini","year":"2022","unstructured":"Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8:5.","journal-title":"Nat Rev Dis Primers"},{"key":"3498_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4078\/jrd.2017.24.3.131","volume":"24","author":"K Young Dae","year":"2017","unstructured":"Young Dae K, Alan VJ, Woojin C. Differential diagnosis of Juvenile Idiopathic Arthritis. J Rheumatic Dis. 2017;24:131\u20137.","journal-title":"J Rheumatic Dis"},{"key":"3498_CR3","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1080\/07853890.2022.2095431","volume":"54","author":"WG Ambler","year":"2022","unstructured":"Ambler WG, Nanda K, Onel KB, Shenoi S. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Ann Med. 2022;54:1839\u201350.","journal-title":"Ann Med"},{"key":"3498_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/art.41390","volume":"72","author":"HI Brunner","year":"2020","unstructured":"Brunner HI, Schanberg LE, Kimura Y, Dennos A, Co DO, Colbert RA, et al. New medications are needed for children with juvenile idiopathic arthritis. Arthritis Rheumatol. 2020;72:1945\u201351.","journal-title":"Arthritis Rheumatol"},{"key":"3498_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7:416\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"3498_CR6","unstructured":"Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Fuhlbrigge RC, Mellins ED. Textbook of Pediatric Rheumatology E-Book. Elsevier Health Sciences; 2020."},{"key":"3498_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41584-023-01042-z","volume":"19","author":"CH Hinze","year":"2023","unstructured":"Hinze CH, Foell D, Kessel C. Treatment of systemic juvenile idiopathic arthritis. Nat Rev Rheumatol. 2023;19:778\u201389.","journal-title":"Nat Rev Rheumatol"},{"key":"3498_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.41107","volume":"72","author":"C Kessel","year":"2020","unstructured":"Kessel C, Hedrich CM, Foell D. Innately adaptive or truly autoimmune: is there something Unique about systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2020;72:210\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"3498_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/art.23437","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Piccini A, Lasigli\u00e8 D, Tassi S, Brisca G, Carta S, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008;58:1505\u201315.","journal-title":"Arthritis Rheum"},{"key":"3498_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","volume":"29","author":"D Chaussabel","year":"2008","unstructured":"Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29:150\u201364.","journal-title":"Immunity"},{"key":"3498_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.38628","volume":"66","author":"L Chiche","year":"2014","unstructured":"Chiche L, Jourde-Chiche N, Whalen E, Presnell S, Gersuk V, Dang K, et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 2014;66:1583\u201395.","journal-title":"Arthritis Rheumatol"},{"key":"3498_CR12","first-page":"477","volume":"56","author":"N Jourde-Chiche","year":"2017","unstructured":"Jourde-Chiche N, Whalen E, Gondouin B, Speake C, Gersuk V, Dussol B, et al. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. Rheumatology (Oxford). 2017;56:477\u201387.","journal-title":"Rheumatology (Oxford)"},{"key":"3498_CR13","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1038\/s41467-021-23472-7","volume":"12","author":"P Soret","year":"2021","unstructured":"Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, et al. A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome. Nat Commun. 2021;12:3523.","journal-title":"Nat Commun"},{"key":"3498_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/kez335","volume":"59","author":"JA James","year":"2020","unstructured":"James JA, Guthridge JM, Chen H, Lu R, Bourn RL, Bean K, et al. Unique Sj\u00f6gren\u2019s syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020;59:860\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"3498_CR15","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/s41467-018-05044-4","volume":"9","author":"S Tasaki","year":"2018","unstructured":"Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat Commun. 2018;9:2755.","journal-title":"Nat Commun"},{"key":"3498_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy\u2013analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307\u201315.","journal-title":"Bioinformatics"},{"key":"3498_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du P, Kibbe WA, Lin SM. Lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008;24:1547\u20138.","journal-title":"Bioinformatics"},{"key":"3498_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327.","journal-title":"Biostatistics"},{"key":"3498_CR19","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom Bioinform. 2020;2:lqaa078.","journal-title":"NAR Genom Bioinform"},{"key":"3498_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41598-020-58766-1","volume":"10","author":"CR John","year":"2020","unstructured":"John CR, Watson D, Russ D, Goldmann K, Ehrenstein M, Pitzalis C, et al. M3C: Monte Carlo reference-based consensus clustering. Sci Rep. 2020;10:1816.","journal-title":"Sci Rep"},{"key":"3498_CR21","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1038\/srep06207","volume":"4","author":"Y \u0218enbabao\u011flu","year":"2014","unstructured":"\u0218enbabao\u011flu Y, Michailidis G, Li JZ. Critical limitations of consensus clustering in class discovery. Sci Rep. 2014;4:6207.","journal-title":"Sci Rep"},{"key":"3498_CR22","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"3498_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.csda.2006.11.025","volume":"52","author":"C Hennig","year":"2007","unstructured":"Hennig C. Cluster-wise assessment of cluster stability. Comput Stat Data Anal. 2007;52:258\u201371.","journal-title":"Comput Stat Data Anal"},{"key":"3498_CR24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3498_CR25","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3498_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3498_CR27","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u201361.","journal-title":"Nucleic Acids Res"},{"key":"3498_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"3498_CR29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 2024;52:D672\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3498_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"3498_CR31","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1038\/s41467-021-24584-w","volume":"12","author":"MC Altman","year":"2021","unstructured":"Altman MC, Rinchai D, Baldwin N, Toufiq M, Whalen E, Garand M, et al. Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data. Nat Commun. 2021;12:4385.","journal-title":"Nat Commun"},{"key":"3498_CR32","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btab121","volume":"37","author":"D Rinchai","year":"2021","unstructured":"Rinchai D, Roelands J, Toufiq M, Hendrickx W, Altman MC, Bedognetti D, et al. BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R. Bioinformatics. 2021;37:2382\u20139.","journal-title":"Bioinformatics"},{"key":"3498_CR33","doi-asserted-by":"publisher","first-page":"103477","DOI":"10.1016\/j.ebiom.2021.103477","volume":"70","author":"Y Deng","year":"2021","unstructured":"Deng Y, Zheng Y, Li D, Hong Q, Zhang M, Li Q, et al. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. EBioMedicine. 2021;70:103477.","journal-title":"EBioMedicine"},{"key":"3498_CR34","doi-asserted-by":"publisher","first-page":"eadg6375","DOI":"10.1126\/sciadv.adg6375","volume":"9","author":"J Guthrie","year":"2023","unstructured":"Guthrie J, K\u00f6stel Bal S, Lombardo SD, M\u00fcller F, Sin C, H\u00fctter CVR, et al. AutoCore: a network-based definition of the core module of human autoimmunity and autoinflammation. Sci Adv. 2023;9:eadg6375.","journal-title":"Sci Adv"},{"key":"3498_CR35","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.patter.2020.100052","volume":"1","author":"A Salavaty","year":"2020","unstructured":"Salavaty A, Ramialison M, Currie P. Integrated Value of Influence: an integrative method for the identification of the most influential nodes within networks. Patterns (N Y). 2020;1:100052.","journal-title":"Patterns (N Y)"},{"key":"3498_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","volume":"6","author":"AB Keenan","year":"2018","unstructured":"Keenan AB, Jenkins SL, Jagodnik KM, Koplev S, He E, Torre D, et al. The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level cataloging of human cells response to perturbations. Cell Syst. 2018;6:13\u201324.","journal-title":"Cell Syst"},{"key":"3498_CR37","doi-asserted-by":"publisher","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","volume":"46","author":"A Koleti","year":"2018","unstructured":"Koleti A, Terryn R, Stathias V, Chung C, Cooper DJ, Turner JP, et al. Data portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. Nucleic Acids Res. 2018;46:D558\u201366.","journal-title":"Nucleic Acids Res"},{"key":"3498_CR38","first-page":"506","volume":"19","author":"A Musa","year":"2018","unstructured":"Musa A, Ghoraie LS, Zhang SD, Glazko G, Yli-Harja O, Dehmer M, et al. A review of connectivity map and computational approaches in pharmacogenomics. Brief Bioinform. 2018;19:506\u201323.","journal-title":"Brief Bioinform"},{"key":"3498_CR39","doi-asserted-by":"publisher","first-page":"vbac064","DOI":"10.1093\/bioadv\/vbac064","volume":"2","author":"I Kwee","year":"2022","unstructured":"Kwee I, Martinelli A, Khayal LA, Akhmedov M. metaLINCS: an R package for meta-level analysis of LINCS L1000 drug signatures using stratified connectivity mapping. Bioinform Adv. 2022;2:vbac064.","journal-title":"Bioinform Adv"},{"key":"3498_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19:135.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3498_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/ard.2007.079533","volume":"68","author":"S Ishikawa","year":"2009","unstructured":"Ishikawa S, Mima T, Aoki C, Yoshio-Hoshino N, Adachi Y, Imagawa T, et al. Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis. Ann Rheum Dis. 2009;68:264\u201372.","journal-title":"Ann Rheum Dis"},{"key":"3498_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","volume":"18","author":"F Gohar","year":"2016","unstructured":"Gohar F, Kessel C, Lavric M, Holzinger D, Foell D. Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther. 2016;18:163.","journal-title":"Arthritis Res Ther"},{"key":"3498_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4078\/jrd.2020.27.4.233","volume":"27","author":"JG Ahn","year":"2020","unstructured":"Ahn JG. Role of biomarkers in Juvenile Idiopathic Arthritis. J Rheumatic Dis. 2020;27:233\u201340.","journal-title":"J Rheumatic Dis"},{"key":"3498_CR44","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3899\/jrheum.121131","volume":"40","author":"M Gorelik","year":"2013","unstructured":"Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, et al. Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2013;40:1191\u20139.","journal-title":"J Rheumatol"},{"key":"3498_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2020-217470","volume":"80","author":"GS Schulert","year":"2021","unstructured":"Schulert GS, Pickering AV, Do T, Dhakal S, Fall N, Schnell D, et al. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-\u03b3 hyper-responsiveness and risk for macrophage activation syndrome. Ann Rheum Dis. 2021;80:617\u201325.","journal-title":"Ann Rheum Dis"},{"key":"3498_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13075-016-1212-x","volume":"19","author":"AH Brachat","year":"2017","unstructured":"Brachat AH, Grom AA, Wulffraat N, Brunner HI, Quartier P, Brik R, et al. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Arthritis Res Ther. 2017;19:13.","journal-title":"Arthritis Res Ther"},{"key":"3498_CR47","unstructured":"Uhlen MA-O, Karlsson MA-O, Zhong WA-O, Tebani AA-O, Pou CA-OX, Mikes JA-O et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. LID - eaax9198 [pii] LID\u2013\u200910.1126\/science.aax9198 [doi]."},{"key":"3498_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19:177\u201391.","journal-title":"Cell Mol Immunol"},{"key":"3498_CR49","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/art.42104","volume":"74","author":"B Malengier-Devlies","year":"2022","unstructured":"Malengier-Devlies B, Bernaerts E, Ahmadzadeh K, Filtjens J, Vandenhaute J, Boeckx B, et al. Role for Granulocyte colony-stimulating factor in Neutrophilic Extramedullary myelopoiesis in a murine model of systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2022;74:1257\u201370.","journal-title":"Arthritis Rheumatol"},{"key":"3498_CR50","doi-asserted-by":"publisher","first-page":"775267","DOI":"10.3389\/fimmu.2021.775267","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Li Y, Sun R, Hu H, Liu Y, Herrmann M, et al. Receptor-mediated NETosis on neutrophils. Front Immunol. 2021;12:775267.","journal-title":"Front Immunol"},{"key":"3498_CR51","doi-asserted-by":"crossref","unstructured":"Kim JW, Ahn MH, Jung JY, Suh CH, Kim HA. An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still\u2019s Disease. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms222313038"},{"key":"3498_CR52","doi-asserted-by":"publisher","first-page":"102929","DOI":"10.1016\/j.jaut.2022.102929","volume":"133","author":"S Tang","year":"2022","unstructured":"Tang S, Yang C, Li S, Ding Y, Zhu D, Ying S, et al. Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome. J Autoimmun. 2022;133:102929.","journal-title":"J Autoimmun"},{"key":"3498_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","volume":"48","author":"CL Evavold","year":"2018","unstructured":"Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The pore-forming protein gasdermin D regulates Interleukin-1 secretion from living macrophages. Immunity. 2018;48:35\u2013e446.","journal-title":"Immunity"},{"key":"3498_CR54","doi-asserted-by":"publisher","first-page":"eabj3859","DOI":"10.1126\/sciimmunol.abj3859","volume":"6","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, et al. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 2021;6:eabj3859.","journal-title":"Sci Immunol"},{"key":"3498_CR55","doi-asserted-by":"crossref","unstructured":"Sollberger G, Choidas A, Burn GL, Habenberger P, Di Lucrezia R, Kordes S et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol. 2018;3.","DOI":"10.1126\/sciimmunol.aar6689"},{"key":"3498_CR56","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1002\/art.38875","volume":"66","author":"SW Eng","year":"2014","unstructured":"Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS. The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66:3463\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"3498_CR57","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00018-018-2805-0","volume":"75","author":"A Mattiotti","year":"2018","unstructured":"Mattiotti A, Prakash S, Barnett P, van den Hoff MJB. Follistatin-like 1 in development and human diseases. Cell Mol Life Sci. 2018;75:2339\u201354.","journal-title":"Cell Mol Life Sci"},{"key":"3498_CR58","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778\u201395.","journal-title":"Immunity"},{"key":"3498_CR59","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"CA Dinarello","year":"2019","unstructured":"Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol. 2019;15:612\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"3498_CR60","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.3389\/fimmu.2018.02995","volume":"9","author":"RA Brown","year":"2018","unstructured":"Brown RA, Henderlight M, Do T, Yasin S, Grom AA, DeLay M, et al. Neutrophils from children with systemic juvenile idiopathic arthritis exhibit Persistent Proinflammatory Activation despite Long-Standing clinically inactive disease. Front Immunol. 2018;9:2995.","journal-title":"Front Immunol"},{"key":"3498_CR61","doi-asserted-by":"crossref","unstructured":"Kim M, Choe Y-h, Lee S-i. Lessons from the success and failure of targeted drugs for rheumatoid arthritis: perspectives for Effective Basic and Translational Research. Immune Netw. 2022;22.","DOI":"10.4110\/in.2022.22.e8"},{"key":"3498_CR62","doi-asserted-by":"crossref","unstructured":"Hoffmeister L, Diekmann M, Brand K, Huber R. GSK3: a kinase balancing Promotion and Resolution of inflammation. Cells. 2020;9.","DOI":"10.3390\/cells9040820"},{"key":"3498_CR63","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jbspin.2013.09.006","volume":"81","author":"YJ Kwon","year":"2014","unstructured":"Kwon YJ, Yoon CH, Lee SW, Park YB, Lee SK, Park MC. Inhibition of glycogen synthase kinase-3\u03b2 suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis. Joint Bone Spine. 2014;81:240\u20136.","journal-title":"Joint Bone Spine"},{"key":"3498_CR64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni1221","volume":"6","author":"M Martin","year":"2005","unstructured":"Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005;6:777\u201384.","journal-title":"Nat Immunol"},{"key":"3498_CR65","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR. Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol. 2021;22:346\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3498_CR66","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/febs.13250","volume":"282","author":"J Gupta","year":"2015","unstructured":"Gupta J, Nebreda AR. Roles of p38\u03b1 mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. Febs j. 2015;282:1841\u201357.","journal-title":"Febs j"},{"key":"3498_CR67","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI5257","volume":"103","author":"JA Nick","year":"1999","unstructured":"Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, et al. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest. 1999;103:851\u20138.","journal-title":"J Clin Invest"},{"key":"3498_CR68","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1126\/science.1156037","volume":"320","author":"TM Thornton","year":"2008","unstructured":"Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science. 2008;320:667\u201370.","journal-title":"Science"},{"key":"3498_CR69","doi-asserted-by":"publisher","first-page":"30476","DOI":"10.1074\/jbc.M705783200","volume":"282","author":"AN Abell","year":"2007","unstructured":"Abell AN, Granger DA, Johnson GL. MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta. J Biol Chem. 2007;282:30476\u201384.","journal-title":"J Biol Chem"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03498-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:57:39Z","timestamp":1738997859000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03498-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3498"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03498-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All raw data used in this study are available in a public, open-access repository and only summary-level datasets without participants were utilized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}